TSPYL2 is an essential component of the REST/NRSF transcriptional complex for TGFβ signaling activation

Cell Death and Differentiation

Volumn 22, Issue 8, 2015, Pages 1353-1362

  Epping, M T ^a   Lunardi, A ^a   Nachmani, D ^a   Castillo Martin, M ^b   Thin, T H ^b   Cordon Cardo, C ^a   Pandolfi, P P ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; NUCLEAR FACTOR; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR REST; TRANSFORMING GROWTH FACTOR BETA; TSPYL2 PROTEIN; TYROSINE KINASE RECEPTOR; TYROSINE KINASE RECEPTOR C; UNCLASSIFIED DRUG; NUCLEAR PROTEIN; RE1-SILENCING TRANSCRIPTION FACTOR; REPRESSOR PROTEIN; TSPYL2 PROTEIN, HUMAN;

A549 CELL LINE; ARTICLE; BREAST CANCER; BREAST EPITHELIUM CELL; CANCER CELL LINE; CELL CYCLE ARREST; CELL PROLIFERATION; CONTROLLED STUDY; GENE REPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN PURIFICATION; PROTO ONCOGENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; WESTERN BLOTTING; CHROMATIN IMMUNOPRECIPITATION; DRUG EFFECTS; GENETICS; METABOLISM; PHYSIOLOGY; TUMOR CELL LINE;

BLOTTING, WESTERN; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; HUMANS; MASS SPECTROMETRY; NUCLEAR PROTEINS; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 84935687993     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2014.226     Document Type: Article

References (40)

1. Chong JA, Tapia-Ramirez J, Kim S, Toledo-Aral JJ, Zheng Y, Boutros MC et al. REST: a mammalian silencer protein that restricts sodium channel gene expression to neurons. Cell 1995; 80: 949-957.
2. Schoenherr CJ, Anderson DJ. The neuron-restrictive silencer factor (NRSF): a coordinate repressor of multiple neuron-specific genes. Science 1995; 267: 1360-1363.
3. Ballas N, Grunseich C, Lu DD, Speh JC, Mandel G. REST and its corepressors mediate plasticity of neuronal gene chromatin throughout neurogenesis. Cell 2005; 121: 645-657.
4. Ballas N, Mandel G. The many faces of REST oversee epigenetic programming of neuronal genes. Curr Opin Neurobiol 2005; 15: 500-506.
5. Majumder S. REST in good times and bad: roles in tumor suppressor and oncogenic activities. Cell Cycle 2006; 5: 1929-1935.
6. Westbrook TF, Martin ES, Schlabach MR, Leng Y, Liang AC, Feng B et al. A genetic screen for candidate tumor suppressors identifies REST. Cell 2005; 121: 837-848.
7. Kreisler A, Strissel PL, Strick R, Neumann SB, Schumacher U, Becker CM. Regulation of the NRSF/REST gene by methylation and CREB affects the cellular phenotype of small-cell lung cancer. Oncogene 2010; 29: 5828-5838.
8. Wagoner MP, Gunsalus KT, Schoenike B, Richardson AL, Friedl A, Roopra A. The transcription factor REST is lost in aggressive breast cancer. PLoS Genet 2010; 6: e1000979.
9. Epping MT, Meijer LA, Krijgsman O, Bos JL, Pandolfi PP, Bernards R. TSPYL5 suppresses p53 levels and function by physical interaction with USP7. Nat Cell Biol 2011; 13: 102-108.
10. Kandalaft LE, Zudaire E, Portal-Nunez S, Cuttitta F, Jakowlew SB. Differentially expressed nucleolar transforming growth factor-beta1 target (DENTT) exhibits an inhibitory role on tumorigenesis. Carcinogenesis 2008; 29: 1282-1289.
11. Chai Z, Sarcevic B, Mawson A, Toh BH. SET-related cell division autoantigen-1 (CDA1) arrests cell growth. J Biol Chem2001; 276: 33665-33674.
12. Tu Y, Wu W, Wu T, Cao Z, Wilkins R, Toh BH et al. Antiproliferative autoantigen CDA1 transcriptionally up-regulates p21(Waf1/Cip1) by activating p53 and MEK/ERK1/2 MAPK pathways. J Biol Chem2007; 282: 11722-11731.
13. Pham Y, Tu Y, Wu T, Allen TJ, Calkin AC, Watson AM et al. Cell division autoantigen 1 plays a profibrotic role by modulating downstream signalling of TGF-beta in a murine diabetic model of atherosclerosis. Diabetologia 2010; 53: 170-179.
14. Tu Y, Wu T, Dai A, Pham Y, Chew P, de Haan JB et al. Cell division autoantigen 1 enhances signaling and the profibrotic effects of transforming growth factor-beta in diabetic nephropathy. Kidney Int 2011; 79: 199-209.
15. Ozbun LL, Martinez A, Jakowlew SB. Differentially expressed nucleolar TGF-beta1 target (DENTT) shows tissue-specific nuclear and cytoplasmic localization and increases TGFbeta1-responsive transcription in primates. Biochim Biophys Acta 2005; 1728: 163-180.
16. Siegel PM, Massague J. Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat Rev Cancer 2003; 3: 807-821.
17. Derynck R, Akhurst RJ, Balmain A. TGF-beta signaling in tumor suppression and cancer progression. Nat Genet 2001; 29: 117-129.
18. Grimes JA, Nielsen SJ, Battaglioli E, Miska EA, Speh JC, Berry DL et al. The co-repressor mSin3A is a functional component of the REST-CoREST repressor complex. J Biol Chem2000; 275: 9461-9467.
19. Andres ME, Burger C, Peral-Rubio MJ, Battaglioli E, Anderson ME, Grimes J et al. CoREST: a functional corepressor required for regulation of neural-specific gene expression. Proc Natl Acad Sci USA 1999; 96: 9873-9878.
20. Lunyak VV, Burgess R, Prefontaine GG, Nelson C, Sze SH, Chenoweth J et al. Corepressordependent silencing of chromosomal regions encoding neuronal genes. Science 2002; 298: 1747-1752.
21. Zeng W, Kong Q, Li C, Mao B. Xenopus RCOR2 (REST corepressor 2) interacts with ZMYND8, which is involved in neural differentiation. Biochem Biophys Res Commun 2010; 394: 1024-1029.
22. You A, Tong JK, Grozinger CM, Schreiber SL. CoREST is an integral component of the CoREST-human histone deacetylase complex. Proc Natl Acad Sci USA 2001; 98: 1454-1458.
23. Ballas N, Battaglioli E, Atouf F, Andres ME, Chenoweth J, Anderson ME et al. Regulation of neuronal traits by a novel transcriptional complex. Neuron 2001; 31: 353-365.
24. Roopra A, Sharling L, Wood IC, Briggs T, Bachfischer U, Paquette AJ et al. Transcriptional repression by neuron-restrictive silencer factor is mediated via the Sin3-histone deacetylase complex. Mol Cell Biol 2000; 20: 2147-2157.
25. Naruse Y, Aoki T, Kojima T, Mori N. Neural restrictive silencer factor recruits mSin3 and histone deacetylase complex to repress neuron-specific target genes. Proc Natl Acad Sci USA 1999; 96: 13691-13696.
26. Huang Y, Myers SJ, Dingledine R. Transcriptional repression by REST: recruitment of Sin3A and histone deacetylase to neuronal genes. Nat Neurosci 1999; 2: 867-872.
27. Kortlever RM, Nijwening JH, Bernards R. Transforming growth factor-beta requires its target plasminogen activator inhibitor-1 for cytostatic activity. J Biol Chem2008; 283: 24308-24313.
28. Dennler S, Itoh S, Vivien D, ten Dijke P, Huet S, Gauthier JM. Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J 1998; 17: 3091-3100.
29. Mulligan P, Westbrook TF, Ottinger M, Pavlova N, Chang B, Macia E et al. CDYL bridges REST and histone methyltransferases for gene repression and suppression of cellular transformation. Mol Cell 2008; 32: 718-726.
30. Douma S, Van Laar T, Zevenhoven J, Meuwissen R, Van Garderen E, Peeper DS. Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB. Nature 2004; 430: 1034-1039.
31. Li Z, Tognon CE, Godinho FJ, Yasaitis L, Hock H, Herschkowitz JI et al. ETV6-NTRK3 fusion oncogene initiates breast cancer from committed mammary progenitors via activation of AP1 complex. Cancer Cell 2007; 12: 542-558.
32. Tognon C, Knezevich SR, Huntsman D, Roskelley CD, Melnyk N, Mathers JA et al. Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma. Cancer Cell 2002; 2: 367-376.
33. Knezevich SR, McFadden DE, Tao W, Lim JF, Sorensen PH. A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma. Nat Genet 1998; 18: 184-187.
34. Eguchi M, Eguchi-Ishimae M, Tojo A, Morishita K, Suzuki K, Sato Y et al. Fusion of ETV6 to neurotrophin-3 receptor TRKC in acute myeloid leukemia with t(12;15)(p13;q25). Blood 1999; 93: 1355-1363.
35. Jin W, Yun C, Kwak MK, Kim TA, Kim SJ. TrkC binds to the type II TGF-beta receptor to suppress TGF-beta signaling. Oncogene 2007; 26: 7684-7691.
36. Jin W, Kim BC, Tognon C, Lee HJ, Patel S, Lannon CL et al. The ETV6-NTRK3 chimeric tyrosine kinase suppresses TGF-beta signaling by inactivating the TGF-beta type II receptor. Proc Natl Acad Sci USA 2005; 102: 16239-16244.
37. Sometani A, Kataoka H, Nitta A, Fukumitsu H, Nomoto H, Furukawa S. Transforming growth factor-beta1 enhances expression of brain-derived neurotrophic factor and its receptor, TrkB, in neurons cultured from rat cerebral cortex. J Neurosci Res2001; 66: 369-376.
38. Pierce DF Jr., Johnson MD, Matsui Y, Robinson SD, Gold LI, Purchio AF et al. Inhibition of mammary duct development but not alveolar outgrowth during pregnancy in transgenic mice expressing active TGF-beta 1. Genes Dev1993; 7: 2308-2317.
39. Moses H, Barcellos-Hoff MH. TGF-beta biology in mammary development and breast cancer. Cold Spring Harb Perspect Biol2011; 3: a003277.
40. Jin W, Kim GM, Kim MS, Lim MH, Yun C, Jeong J et al. TrkC plays an essential role in breast tumor growth and metastasis. Carcinogenesis 2010; 31: 1939-1947.